These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1063 related articles for article (PubMed ID: 28838210)

  • 1. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
    Curigliano G; Burstein HJ; Winer EP; Gnant M; Dubsky P; Loibl S; Colleoni M; Regan MM; Piccart-Gebhart M; Senn HJ; Thürlimann B; ; André F; Baselga J; Bergh J; Bonnefoi H; Brucker SY; Cardoso F; Carey L; Ciruelos E; Cuzick J; Denkert C; Di Leo A; Ejlertsen B; Francis P; Galimberti V; Garber J; Gulluoglu B; Goodwin P; Harbeck N; Hayes DF; Huang CS; Huober J; Hussein K; Jassem J; Jiang Z; Karlsson P; Morrow M; Orecchia R; Osborne KC; Pagani O; Partridge AH; Pritchard K; Ro J; Rutgers EJT; Sedlmayer F; Semiglazov V; Shao Z; Smith I; Toi M; Tutt A; Viale G; Watanabe T; Whelan TJ; Xu B
    Ann Oncol; 2017 Aug; 28(8):1700-1712. PubMed ID: 28838210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
    Coates AS; Winer EP; Goldhirsch A; Gelber RD; Gnant M; Piccart-Gebhart M; Thürlimann B; Senn HJ;
    Ann Oncol; 2015 Aug; 26(8):1533-46. PubMed ID: 25939896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023.
    Curigliano G; Burstein HJ; Gnant M; Loibl S; Cameron D; Regan MM; Denkert C; Poortmans P; Weber WP; Thürlimann B;
    Ann Oncol; 2023 Nov; 34(11):970-986. PubMed ID: 37683978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
    Burstein HJ; Curigliano G; Loibl S; Dubsky P; Gnant M; Poortmans P; Colleoni M; Denkert C; Piccart-Gebhart M; Regan M; Senn HJ; Winer EP; Thurlimann B;
    Ann Oncol; 2019 Oct; 30(10):1541-1557. PubMed ID: 31373601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. St. Gallen/Vienna 2017: A Brief Summary of the Consensus Discussion about Escalation and De-Escalation of Primary Breast Cancer Treatment.
    Gnant M; Harbeck N; Thomssen C
    Breast Care (Basel); 2017 May; 12(2):102-107. PubMed ID: 28559767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017: Egyptian view.
    Khaled H; Gamal H; Lotayef M; Knauer M; Thürliman B
    Breast Cancer Res Treat; 2018 Dec; 172(3):545-550. PubMed ID: 30218194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer.
    Morigi C
    Ecancermedicalscience; 2017; 11():732. PubMed ID: 28491135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
    Goldhirsch A; Winer EP; Coates AS; Gelber RD; Piccart-Gebhart M; Thürlimann B; Senn HJ;
    Ann Oncol; 2013 Sep; 24(9):2206-23. PubMed ID: 23917950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015).
    Untch M; Harbeck N; Huober J; von Minckwitz G; Gerber B; Kreipe HH; Liedtke C; Marschner N; Möbus V; Scheithauer H; Schneeweiss A; Thomssen C; Jackisch C; Beckmann MW; Blohmer JU; Costa SD; Decker T; Diel I; Fasching PA; Fehm T; Janni W; Lück HJ; Maass N; Scharl A; Loibl S
    Geburtshilfe Frauenheilkd; 2015 Jun; 75(6):556-565. PubMed ID: 26166836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
    Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
    Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017).
    Untch M; Huober J; Jackisch C; Schneeweiss A; Brucker SY; Dall P; Denkert C; Fasching PA; Fehm T; Gerber B; Janni W; Kühn T; Lüftner D; Möbus V; Müller V; Rody A; Sinn P; Thill M; Thomssen C; Harbeck N; Liedtke C
    Geburtshilfe Frauenheilkd; 2017 Jun; 77(6):633-644. PubMed ID: 28769126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highlights of the 16th St Gallen International Breast Cancer Conference, Vienna, Austria, 20-23 March 2019: personalised treatments for patients with early breast cancer.
    Morigi C
    Ecancermedicalscience; 2019; 13():924. PubMed ID: 31281421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.
    Burstein HJ; Curigliano G; Thürlimann B; Weber WP; Poortmans P; Regan MM; Senn HJ; Winer EP; Gnant M;
    Ann Oncol; 2021 Oct; 32(10):1216-1235. PubMed ID: 34242744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion.
    Gnant M; Thomssen C; Harbeck N
    Breast Care (Basel); 2015 Apr; 10(2):124-30. PubMed ID: 26195941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    Eifel P; Axelson JA; Costa J; Crowley J; Curran WJ; Deshler A; Fulton S; Hendricks CB; Kemeny M; Kornblith AB; Louis TA; Markman M; Mayer R; Roter D
    J Natl Cancer Inst; 2001 Jul; 93(13):979-89. PubMed ID: 11438563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of breast cancer in countries with limited resources.
    Carlson RW; Anderson BO; Chopra R; Eniu AE; Jakesz R; Love RR; Masetti R; Schwartsmann G;
    Breast J; 2003; 9 Suppl 2():S67-74. PubMed ID: 12713499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
    Goldhirsch A; Wood WC; Coates AS; Gelber RD; Thürlimann B; Senn HJ;
    Ann Oncol; 2011 Aug; 22(8):1736-47. PubMed ID: 21709140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.